Medical Dosimetry
Volume 31, Issue 1 , Pages 3-11 , Spring 2006

Advances in image-guided radiation therapy—the role of PET-CT

,Accepted 21 December 2005.

References 

  1. Gambhir SS , Czernin J , Schwimmer J , et al.   A tabulated summary of the FDG PET literature . J. Nucl. Med. . 2002;42:1S–93S
  2. Maurer AH , Urbain J-LC , Malmud LS , et al.   Grainger & Allison’s Diagnostic Radiology (A Textbook of Medical Imaging) . 4th ed.. London: Churchill Livingstone, Inc; 2001;
  3. Schoder H , Erdi YE , Larson SM , et al.   PET/CT (A new imaging technology in nuclear medicine) . Eur. J. Nucl. Med. Mol. Imaging. . 2003;30:1419–1437
  4. Schwartz DL , Ford E , Rajendran J , et al.   FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma . Int. J. Radiat. Oncol. Biol. Phys. . 2005;61:129–136
  5. Heron DE , Andrade RS , Flickinger J , et al.   Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers (A brief technical report) . Int. J. Radiat. Oncol. Biol. Phys. . 2004;60:1419–1424
  6. Vansteenkiste JF , Stroobants SG , Dupont PJ , et al.  The Leuven Lung Cancer Group   FDG-PET scan in potentially operable non-small cell lung cancer (Do anatometabolic PET-CT fusion images improve the localization of regional lymph node metastases?) . Eur. J. Nucl. Med. . 1998;25:1495–1501
  7. Steinert HC , Hauser M , Allemann F , et al.   Non-small cell lung cancer (Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling) . Radiology . 1997;202:441–446
  8. Pieterman RM , van Putten JW , Meuzelaar JJ , et al.   Preoperative staging of non-small-cell lung cancer with positron-emission tomography . N. Engl. J. Med. . 2000;343:254–261
  9. Poncelet AJ , Lonneux M , Coche E , et al.   PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma . Eur. J. Cardiothorac. Surg. . 2001;20:468–475
  10. Toloza E , Harpole L , McCrory DC . Noninvasive staging of non-small cell lung cancer, a review of the current evidence . Chest . 2003;123:137S–146S
  11. Reske SN , Kotzerke J . FDG-PET for clinical use (Results of the 3rd German Interdisciplinary Consensus Conference) . Eur. J. Nucl. Med. . 2001;28:1707–1723
  12. Roberts PF , Follette DM , von Haag D , et al.   Factors associated with false-positive staging of lung cancer by positron emission tomography . Ann. Thorac. Surg. . 2000;70:1154–1160
  13. Liewald F , Grosse S , Storck M , et al.   How useful is positron emission tomography for lymph node staging in non-small-cell lung cancer? . Thorac. Cardiovasc. Surg. . 2000;48:93–96
  14. van Tinteren H , Hoekstra OS , Smit EF , et al.   Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer (The PLUS multicentre randomized trial) . Lancet . 2002;359:1388–1393
  15. Mac Manus MP , Hicks RJ , Ball DL , et al.   F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma (Powerful correlation with survival and high impact on treatment) . Cancer . 2001;92:886–895
  16. Griesinger F , Overbeck T , Dörge B , et al.   Phase II induction therapy with docetaxel and carboplatin in NSCLC IIIA/IIIB: FDG-PET response predicts overall and disease-free survival. 2005 ASCO Annual Meeting Proceedings . J. Clin. Oncol. . 2005;23:7184
  17. Pfister DG , Johnson DH , Azzoli CG , et al.   American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline (Update 2003) . J. Clin. Oncol. . 2004;22:330–353
  18. Magnani P , Carretta A , Rizzo G , et al.   FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients . J. Cardiovasc. Surg. . 1999;40:741–748
  19. Holloway CL , Robinson D , Murray B , et al.   Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer . Radiother. Oncol. . 2004;73:285–287
  20. Ruysscher DD , Wanders S , Minken A , et al.   Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation (A planning study) . Radiother. Oncol . 2005;77:5–10
  21. Schmuecking M , Schneider CP , Soeldner J , et al.   What is the role of F-18 FDG PET within randomized multicenter clinical trials for multi-modality treatment of non-small cell lung cancer stage III? 2005 ASCO Annual Meeting Proceedings . J. Clin. Oncol. . 2005;23:7182
  22. Deniaud-Alexandre E , Touboul E , Lerouge D , et al.   Impact of computed tomography and (18)F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cankering . Int. J. Radiat. Oncol. Biol. Phys. . 2005;63:1432–1441
  23. Ashamalla H , Rafla S , Parikh K , et al.   The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer . Int. J. Radiat. Oncol. Biol. Phys. . 2005;63:1016–1023
  24. Schirrmeister H , Glatting G , Hetzel J , et al.   Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer . J. Nucl. Med. . 2001;42:1800–1804
  25. Erasmus JJ , Patz EF , McAdams HP , et al.   Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography . Am. J. Roentgenol . 1997;168:1357–1360
  26. Yun M , Kim W , Alnafisi N , et al.   18F-FDG PET in characterizing adrenal lesions detected on CT or MRI . J. Nucl. Med. . 2001;42:1795–1799
  27. Lowe VJ , Fletcher JW , Gobar L , et al.   Prospective investigation of positron emission tomography in lung nodules . J. Clin. Oncol. . 1998;16:1075–1084
  28. Erasmus JJ , McAdams HP , Rossi SE , et al.   FDG PET of pleural effusions in patients with non-small cell lung cancer . Am. J. Roentgenol. . 2000;175:245–249
  29. Marom EM , McAdams HP , Erasmus JJ , et al.   Staging non-small cell lung cancer with whole-body PET . Radiology . 1999;212:803–809
  30. Hauber HP , Bohuslavizki KH , Lund CH , et al.   Positron emission tomography in the staging of small cell lung cancer (A preliminary study) . Chest . 2001;119:950–954
  31. Schumacher T , Brink I , Mix M , et al.   FDG-PET imaging for the staging and follow up of small cell lung cancer . Eur. J. Nucl. Med. . 2001;28:483–488
  32. Bradley JD , Dehdashti F , Mintun MA , et al.   Positron emission tomography in limited-stage small-cell lung cancer (A prospective study) . J. Clin. Oncol. . 2004;22:3248–3254
  33. Craig MD , Rogers JS , Gupta N . Evaluation of PET scan in small cell lung cancer. 2004 ASCO Annual Meeting Proceedings . J. Clin. Oncol. . 2004;22:7214
  34. Brianzoni E , Rossi G , Ancidei S , et al.   Radiotherapy planning (PET/CT scanner performances in the definition of gross tumour volume and clinical target volume) . Eur. J. Nucl. Med. Mol. Imaging . 2005;32:1392–1399
  35. Flores RM , Akhurst T , Gonen M , et al.   FDG-PET predicts survival in patients with malignant pleural mesothelioma . Proc. Am. Soc. Clin. Oncol. . 2003;22:620
  36. Melotti B , Marino A , Pinto C , et al.   Positron emission tomography (PET) with F18-fluorodeoxyglucose (18F-FDG) in the clinical evaluation of malignant pleural mesothelioma (MPM) . Proc. Am. Soc. Clin. Oncol. . 2003;22:695
  37. Steinert HC , Santos Dellea MM , Burger C , et al.   Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging . Lung Cancer . 2005;49:S33–S35
  38. Grigsby PW , Siegel BA , Dehdashti F . Lymph node staging by positron emission tomography in patients with carcinoma of the cervix . J. Clin. Oncol. . 2001;19:3745–3749
  39. Tran BN , Grigsby PW , Dehdashti F , et al.   Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix . Gynecol. Oncol. . 2003;90:572–576
  40. Colonello, K.; Heron, D.E.; Lalonde, R.J.; et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol. Oncol. Epub 2005.
  41. Bristow RE , Simpkins F , Pannu HK , et al.   Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer . Gynecol. Oncol. . 2002;85:196–200
  42. Jimenez Bonilla J , Moya Garcia F , Zomeno Rodriguez M , et al.   [Detection of relapse in ovarian cancer by PET-FDG] . [Spanish] Rev. Esp. Med. Nucl. . 2001;20:128–129
  43. Makhija S , Howden N , Edwards R , et al.   Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma (A retrospective review) . Gynecol. Oncol. . 2002;85:53–58
  44. Avril N , Sassen S , Schmalfeldt B , et al.   Prediction of response to neoadjuvant chemotherapy by sequential F-18-flurodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer . J. Clin. Oncol . 2005;23:7445–7453
  45. Cohn DE , Dehdashti F , Gibb RK , et al.   Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer . Gynecol. Oncol. . 2002;85:179–184
  46. King G , Yap J , Gerszten K , et al.   PET-CT alters management of patients with gynecologic cancers . 2002; ASCO, May 18–21, Orlando, FL.
  47. Nakamoto Y , Saga T , Ishimori T , et al.   Clinical value of positron emission tomography with FDG for recurrent ovarian cancer . Am. J. Roentgenol. . 2001;176:1449–1454
  48. Grigsby PW , Mutch DG , Rader J , et al.   Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix . Int. J. Radiat. Oncol. Biol. Phys. . 2005;61:444–449
  49. Cohn DE , Dehdashti F , Gibb RK , et al.   Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Clinical Trial . Gynecol. Oncol . 2002;85:179–184
  50. Nakamoto Y , Eisbruch A , Achtyes ED , et al.   Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy . Gynecol. Oncol. . 2002;84:289–295
  51. Horowitz NS , Dehdashti F , Herzog TJ , et al.   Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer . Gynecol. Oncol. . 2004;95:546–551
  52. Lamoreaux WT , Grigsby PW , Dehdashti F , et al.   FDG-PET evaluation of vaginal carcinoma . Int. J. Radiat. Oncol. Biol. Phys. . 2005;62:733–737
  53. Flamen P , Lerut A , Van Cutsem E , et al.   Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma . J. Clin. Oncol. . 2000;18:3202–3210
  54. Meltzer CC , Luketich JD , Friedman D , et al.   Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography . Clin. Nucl. Med. . 2000;25:882–887
  55. van Westreenen HL , Heeren PA , van Dullemen HM , et al.   Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations . J. Gastrointest. Surg . 2005;9:54–61
  56. Duong CP , Hicks RJ , Weih L , et al.   Positive impact of FDG-PET on survival of esophageal cancer patients. 2004 ASCO Annual Meeting Proceedings . J. Clin. Oncol. . 2004;2:4055
  57. Song SY , Kim JH , Ryu JS , et al.   FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer . Int. J. Radiat. Oncol. Biol. Phys. . 2005;15:1053–1059
  58. Lim L , Michael M , Hicks R , et al.   The impact of PET/CT scanning on the staging and management of esophageal cancer . J. Gastrointest. Surg. . 2005;9:54–61
  59. Bar-Shalom R , Yefremov N , Guralnik L , et al.   Clinical performance of PET/CT in evaluation of cancer (Additional value for diagnostic imaging and patient management) . J. Nucl. Med. . 2003;44:1200–1209
  60. Huebner RH , Park KC , Shepherd JE , et al.   A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer . J. Nucl. Med. . 2000;41:1177–1189
  61. Desai DC , Zervos EE , Arnold MW , et al.   Positron emission tomography affects surgical management in recurrent colorectal cancer patients . Ann. Surg. Oncol. . 2003;10:59–64
  62. Larson SM , Schoder H , Yeung H . Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer . Cancer J. . 2004;10:243–250
  63. Veit P , Kuehle C , Beyer T , et al.   Whole-body PET/CT tumour staging with integrated PET/CT-colonography (Technical feasibility and first experiences in patients with colorectal cancer) . Gut . 2005;55:68–73
  64. Kim JH , Czernin J , Allen-Auerbach MS , et al.   Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer . J. Nucl. Med. . 2005;46:587–595
  65. Even-Sapir E , Parag Y , Lerman H , et al.   Detection of recurrence in patients with rectal cancer (PET/CT after abdominoperineal or anterior resection) . Radiology . 2004;232:815–822
  66. Kasperk RK , Riesener KP , Wilms K , et al.   Limited value of positron emission tomography in treatment of pancreatic cancer (Surgeon’s view) . World J. Surg. . 2001;25:1134–1139
  67. Lemke AJ , Niehues SM , Hosten N , et al.   Retrospective digital image fusion of multidetector CT and 18F-FDG PET (Clinical value in pancreatic lesions—a prospective study with 104 patients) . J. Nucl. Med. . 2004;45:1279–1286
  68. Heinrich S , Goerres GW , Schafer M , et al.   Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness . Ann. Surg. . 2005;242:235–243
  69. Landry JC , Koshy M , Ghavidel S , et al.   The impact of PET-CT fusion on radiation treatment planning in patients with gastrointestinal tumors. 2004 ASCO Annual Meeting Proceedings . J. Clin. Oncol. . 2004;2:3636
  70. Benard F , Romsa J , Hustinx R . Imaging gliomas with positron emission tomography and single-photon emission computed tomography . Semin. Nucl. Med. . 2003;33:148–162
  71. Wong TZ , van der Westhuizen GJ , Coleman RE . Positron emission tomography imaging of brain tumors . Neuroimaging Clin. North Am. . 2002;12:615–626
  72. Solberg TD , Agazaryan N , Goss BW , et al.   A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy . J. Neurosurg. . 2004;101:381–389
  73. Popperl G , Gotz C , Rachinger W , et al.   Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma . Eur. J. Nucl. Mol. Imaging . 2004;31:1464–1470
  74. Chao ST , Suh JH , Raja S , et al.   The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery . Int. J. Cancer . 2001;96:191–197
  75. Hustinx R , Pourdehnad M , Kaschten B , et al.   PET imaging for differentiating recurrent brain tumor from radiation necrosis . Radiol. Clin. North Am. . 2005;43:35–47
  76. Tsuyuguchi N , Takami T , Sunada I , et al.   Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery-in malignant glioma . Ann. Nucl. Med. . 2004;18:291–296
  77. Beuthien-Baumann B , Hahn G , Winkler C , et al.   Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy . Strahlenther. Onkol. . 2003;179:819–822
  78. Belohlavek O , Simonova G , Kantorova I , et al.   Brain metastases after stereotactic radiosurgery using the Leksell gamma knife (Can FDG PET help to differentiate radionecrosis from tumour progression?) . Eur. J. Nucl. Mol. Imaging . 2003;30:96–100

PII: S0958-3947(05)00204-9

doi: 10.1016/j.meddos.2005.12.006

Medical Dosimetry
Volume 31, Issue 1 , Pages 3-11 , Spring 2006

Article Tools

* Image Usage & Resolution